NuPotential Overview

  • Founded
  • 2004
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $375K
Latest Deal Amount
  • Investors
  • 6

NuPotential General Information

Description

Developer of de-differentiated cell lines designed to re-define multiple lineages and somatic cell nuclear transfer. The company's cell lines develop cells that are used in therapies that reverse the debilitating effects of diabetes, stroke, heart disease, Alzheimer's disease, Parkinson's disease and other afflictions, enabling researchers to identify several promising epigenetic targets and candidate molecules from investigating lead series compounds.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • Louisiana Emerging Technology Center
  • 340, East Parker Boulevard
  • Baton Rouge, LA 70803
  • United States
+1 (225) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NuPotential Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 05-Mar-2014 $375K 00.000 00.00 Completed Generating Revenue
4. Grant 14-Mar-2011 00.000 000 Completed Generating Revenue
3. Early Stage VC 13-Mar-2009 000 000 Completed Generating Revenue
2. Grant 01-Jan-2005 $845K $1M Completed Generating Revenue
1. Early Stage VC $1M $1M Completed Startup
To view NuPotential’s complete valuation and funding history, request access »

NuPotential Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00 00.0 00.0 00 00.0 0.00
Series A2 0,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series A1 1,674,749 $0.001000 8% $1.19 $1.19 1x $1.19 20.35%
To view NuPotential’s complete cap table history, request access »

NuPotential Executive Team (3)

Name Title Board Seat Contact Info
Kenneth Eilertsen Ph.D Founder, President & Board Member
Jong Rim Ph.D Director, Research
Joan Neuscheler Chief Executive Officer & Board Member
To view NuPotential’s complete executive team members history, request access »

NuPotential Board Members (4)

Name Representing Role Since
Chuck Oehler Self Board Member 000 0000
Joan Neuscheler Self Chief Executive Officer & Board Member 000 0000
Kenneth Eilertsen Ph.D NuPotential Founder, President & Board Member 000 0000
Ross Barrett JD BVM Capital Board Member 000 0000
To view NuPotential’s complete board members history, request access »

NuPotential Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
New Orleans BioInnovation Center Accelerator/Incubator Minority 000 0000 000000 0
National Heart Blood and Lung Institute Government 000 0000 000000 0
BVM Capital Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »